Advertisement
MO BIO
MO BIO

The Nutshell

Daily News Roundup

Most Recent

Cloned wolf real, panel says

By | April 27, 2007

A South Korean panel that investigated a pulled wolf cloning study ruled today (April 27) that the research team indeed cloned gray wolves, but committed errors in presenting their findings. The journal Cloning and Stem Cells pulled the study linkurl:earlier this month;http://www.the-scientist.com/news/display/53065/ after the authors asked to make changes to the text. Stay tuned for more in-depth coverage on Monday.

0 Comments

Journal retracts duplicate publication

By | April 26, 2007

The journal Fertility and Sterility has retracted a linkurl:duplicate paper;http://www.the-scientist.com/news/display/53061/ about the use of real-time PCR in premature ovarian failure, following a Korean researcher's linkurl:claim;http://www.the-scientist.com/news/display/52859/ that the work was copied from another paper he co-authored in a Korean journal. The scientist listed on both papers has been barred from contributing to the journal for three years. The paper was retracted because

0 Comments

Flagellar tangle

By | April 25, 2007

Call it a row, a kerfluffle, a spat, or what have you. A linkurl:paper in __PNAS__;http://www.pnas.org/cgi/content/abstract/0700266104v1 has whipped up some convoluted discussion in science and non-science blogs. Here's the basic run down: 1. A group publishes an linkurl:explanation;http://www.pnas.org/cgi/content/abstract/0700266104v1 for the stepwise evolution of the flagellum, an interesting scientific question, which linkurl:intelligent designers (IDers);http://www.the-scientist.com/2007/4

0 Comments

50 plum new grants from HHMI

By | April 12, 2007

Howard Hughes Medical Institute is opening a new competition for US investigators. It plans to fund as many as 50 new researchers by Spring 2008 representing an investment of $600 million. Unlike the traditional HHMI investigator programs which have relied on nominations from the investigator's institution these are open to direct application (similar to a plan they announced in a smaller scale for physician scientists last November). The grants are meant for early career investigators (betwe

0 Comments

We may have been right on Senate stem cell vote

By | April 12, 2007

In December, following the November US midterm elections, Richard Gallagher, the editor of The Scientist, wrote a linkurl:hopeful editorial;http://www.the-scientist.com/article/display/36654/ on the future of stem cell funding in the US. In it, he suggested that the Senate was just one vote shy of the 67-33 vote it would need to overturn a Presidential veto on the bill. He may have been right. Yesterday, the Senate voted 63-34 to approve the Stem Cell Research Enhancement Act. The three senator

0 Comments

Feudin? genetics style

By | April 9, 2007

A nice linkurl:AP story;http://hosted.ap.org/dynamic/stories/H/HATFIELD_MCCOY_SECRET?SITE=PASTR&SECTION=HOME&TEMPLATE=DEFAULT talks about the hypothesis that much of the fuel for the famed Hatfield-McCoy feud might be attributed to Von Hippel-Lindau disease, a rare genetic disorder that predisposes those affected to highly-vascularized tumors. The reasoning is that adrenal tumors might be responsible for many of the McCoys' notorious tempers. There are some great quotes from actual family memb

0 Comments

Stem cell patent dispute: Wisc. fights back

By | April 4, 2007

In the fallout from a linkurl:major decision;http://www.the-scientist.com/news/home/53051/ by the US patent agency to reject key stem cell patents for embryonic linkurl:stem cell research;http://audio.wnyc.org/bl/bl010507d.mp3 held by the Wisconsin Alumni Research Foundation (WARF), Wisconsin Governor Jim Doyle has taken to the airwaves to defend the state's intellectual property. In a linkurl:statement;http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=2583 released yeste

0 Comments

NY stem cells get green light

By | April 2, 2007

The New York State legislature completed its budget yesterday, including a $600 million appropriation to fund stem cell research. For 2007, the state will provide the first $100 million, and the remainder of the money will come out of the Health Insurance Plan (HIP) of New York, with a $50-million-a-year cap not exceeding $500 million. However, it is unclear when the HIP funds will become available. As reported in The Scientist, a few linkurl:versions;http://www.the-scientist.com/news/display

0 Comments

Lessons from Chimeras

By | March 29, 2007

The chimera marmoset story reported linkurl:here;http://www.the-scientist.com/news/home/53033/ and elsewhere is fascinating; I was stunned by the possibility, not heavily noted in a lot of press, that male cells might have made it into the germline of a female - that is XY cells from a male might have developed into eggs in his female twin sister resulting in a live birth. Germline transmission of one's brothers cells is interesting enough, but the idea of XY eggs is particularly interesting --

0 Comments

Cloning and Paperwork

By | March 28, 2007

Ian Wilmut talks about his disappointment in the failure to move forward on human stem cell research involving cloned embryos in today's Hartford Courant. linkurl:Read it here;http://www.courant.com/news/health/hc-ctdolly0328.artmar28,0,4944106.story?coll=hc-headlines-health Obviously the challenges are many, but to blame his failure to receive a license for cloning human embryos on getting behind in the paperwork does seem a bit odd. Wilmut had written for us when he was first applying said

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Mirus Bio LLC
Mirus Bio LLC
Advertisement
HIWIN
HIWIN